Prognostic implications of left ventricular hypertrophy.
about
Gq/11-mediated signaling and hypertrophy in mice with cardiac-specific transgenic expression of regulator of G-protein signaling 2Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophyEchocardiography-based left ventricular mass estimation. How should we define hypertrophy?Losartan reduced connexin43 expression in left ventricular myocardium of spontaneously hypertensive ratsA functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul studyThe relationship between snoring and left ventricular hypertrophy of China: a cross-sectional study.Left ventricular relative wall thickness versus left ventricular mass index in non-cardioembolic stroke patients.Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction.Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart diseaseDeterminants of left ventricular mass in obesity; a cardiovascular magnetic resonance study.Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: data from the PAMELA population.MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in miceE2/ER β Enhances Calcineurin Protein Degradation and PI3K/Akt/MDM2 Signal Transduction to Inhibit ISO-Induced Myocardial Cell Apoptosis.Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients.Toward transcriptional therapies for the failing heart: chemical screens to modulate genesSignaling responses after exposure to 5 alpha-dihydrotestosterone or 17 beta-estradiol in norepinephrine-induced hypertrophy of neonatal rat ventricular myocytesAlterations in cardiac structure and function in hypertensionWhole transcriptome analysis of the fasting and fed Burmese python heart: insights into extreme physiological cardiac adaptationA cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.Left ventricular shape variation in asymptomatic populations: the Multi-Ethnic Study of Atherosclerosis.Progressive regression of left ventricular hypertrophy two years after bariatric surgeryThe role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis.Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor β (TGFβ1)-dependent paracrine mechanism.Metabolic syndrome in hypertensive patients: An unholy alliance.Awareness and Approach towards Hypertension Management among General Practitioners of Western VadodaraRoles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjectsEffect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trialGenetics of hypertension and cardiovascular disease and their interconnected pathways: lessons from large studies.Screening for treatable left ventricular abnormalities in diabetic patients.Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study.Partial normalization of components of metabolic syndrome does not influence prevalent echocardiographic abnormalities: the HyperGEN studyStem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle (2013 Grover Conference Series).Left ventricular hypertrophy in hypertension: its arrhythmogenic potential.Echocardiographic findings and abnormalities in HIV-infected patients: results from a large, prospective, multicenter HIV-heart study.Manganese-enhanced MRI detection of impaired calcium regulation in a mouse model of cardiac hypertrophyAlteration of proximal aorta biophysical properties in patients with end stage renal diseasePrevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeLeft ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction.
P2860
Q21134156-75DD415C-21C8-4A53-91B4-033387FBE28DQ24650679-60FC5DBB-276D-4766-8D73-C82FB04923B0Q24810969-D871495C-4D26-403E-A6DD-71DB2C36C589Q28582203-86F4FDCA-83E9-4824-AC8A-A26412B66E8CQ28748794-6F50E433-6280-411E-8F17-47BDE4CA8306Q30393660-B01CC201-5C67-4678-9DCB-B40D6108C087Q30400419-340B9D98-D1F1-485A-A5C8-DE244BB01D28Q30442265-8B107CE0-2655-4CA6-8A00-1FDCA3E91923Q30480018-BE690BA0-4740-49B1-B686-E7BD1338F791Q30489678-E0EDC9FE-6A82-4350-A0D3-89913722D0C1Q30773601-D460DF60-AC98-4D3F-B8A2-A9171146F783Q33521236-7924A8CF-7E56-484B-A3BA-8B7D6C26D7D5Q33625017-AD15987A-6D30-4613-BAC7-FE782D9C23BCQ33634605-58A3DAC7-01BA-486C-AE5A-357FF6C947C8Q33683749-92074088-D21F-459C-A3B3-D3BEEB0773AAQ33727986-AE358E67-D2F5-447D-A5F7-21D180EA3B97Q33732380-9E8C2648-D9BA-4B48-821D-2D6495F9C09EQ33736492-2C24F33A-948E-4D33-A3B0-4303167A66AEQ34035845-6EDAB071-0995-4583-A153-F6205A1487EFQ34091939-5D522801-9E47-4A3E-A7E4-A1F614056054Q34109480-7CA3D132-B431-4DA7-9FD7-19A01E4E6A4EQ34183974-3DAD803F-40B1-469E-9641-9934480E465CQ34245123-D753674E-E180-4B31-A67D-29E0D866368EQ34251860-BE08A0EA-1BE3-41B0-94B8-FB17A9D89FDFQ34310716-CF23E704-DFE8-469B-892E-FD1BC361929CQ34383040-E906EB44-7CD6-4998-99F5-4B4E506F7061Q34535592-01B99658-7E7F-4FA9-9E41-87DC4904D188Q34561996-E93D6698-B4C5-4B64-8E6E-674F86BBB9F6Q34571157-D5DE5A8E-AA77-40F9-AEF9-5AE60CC2048DQ34713661-017DE6EF-2B47-46F6-BF42-1A3CE1D5DBD2Q35116162-969BDAF2-C7A4-401A-A505-0145F78FE0C0Q35157562-46DC160A-9A73-451D-BCE5-13301D73874DQ35171258-696903F5-5341-433F-AA3A-FF29317BD333Q35517542-3BDC6F5B-F58C-4AAF-B322-C292B6A9B076Q35583519-675713BB-0EE6-4399-978E-F56BCDF113DBQ35660116-9151F433-B3AE-47B8-AB38-D3CBFFB180F2Q35671456-449FC5DA-A248-46CB-B091-0CAD6F2C1045Q35771286-407DBB55-7D02-4EB4-8577-F081909F9A7DQ35772957-F1FE4134-3AAE-4D29-90E9-C2F2E5FD821FQ35852714-929AA3D8-81D6-41D3-88C2-1FB5FB68F94C
P2860
Prognostic implications of left ventricular hypertrophy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prognostic implications of left ventricular hypertrophy.
@ast
Prognostic implications of left ventricular hypertrophy.
@en
Prognostic implications of left ventricular hypertrophy.
@nl
type
label
Prognostic implications of left ventricular hypertrophy.
@ast
Prognostic implications of left ventricular hypertrophy.
@en
Prognostic implications of left ventricular hypertrophy.
@nl
prefLabel
Prognostic implications of left ventricular hypertrophy.
@ast
Prognostic implications of left ventricular hypertrophy.
@en
Prognostic implications of left ventricular hypertrophy.
@nl
P2093
P356
P1476
Prognostic implications of left ventricular hypertrophy.
@en
P2093
P304
P356
10.1067/MHJ.2001.113218
P407
P577
2001-03-01T00:00:00Z